Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Similarly, decreased miR-19a expression in gefitinib-resistant NSCLC cell lines contributes to cell migration, EMT, and gefitinib resistance by negatively regulating c-Met expression and blocking its downstream pathways (such as PI3K-AKT and RAS-ERK pathways) (Cao et al., 2018)
Both are once-weekly injectable medications, yet they cater to different needs: Mounjaro is primarily approved for treating Type 2 diabetes in adults, while Wegovy is focused on chronic weight management in adults and adolescents aged 12 and older
"Lower cost" is not a qualifying medical need under FDA guidance
Schor NF, Rudin CM, Hartman AR, Thompson CB, Tyurina YY, Kagan VE
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
